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Background: Transcatheter arterial chemoembolization (TACE) is an effective treatment for hepatocellular
carcinoma (HCC) that would occasionally lead to energy malnutrition through therapeutic hypoxic stress. We aimed
to clarify the correlation between the energy malnutrition after TACE and low tolerability for hypoxia of
non-tumoral liver before TACE.
Findings: We performed a prospective cohort study involving 100 HCC patients who underwent TACE at Kobe
University Hospital. Indirect calorimetry was performed before and 7 days after TACE, and non-protein respiratory
quotient (npRQ) as an indicator of the energy malnutrition was measured. Blood biochemical examinations were
also performed before TACE. As an indicator of hypoxic marker, des-γ-carboxy prothrombin (DCP) was measured
before TACE. The correlation between npRQ ratio (7 days after/before TACE) and DCP (before TACE) was statistically
examined. Spearman’s correlation coefficient test showed that npRQ ratio (Day 7/Day 0) was significantly related to
DCP (Day 0) (p=0.0481, r=-0.2033). On the other hand, npRQ ratio (Day 7/Day 0) was not related to alpha
fetoprotein (Day 0) (p=0.6254, r=-0.0494).
Conclusions: The npRQ reduction after TACE was related to a high value of DCP before TACE. The energy
malnutrition after TACE would originate from low tolerability for hypoxia of non-tumoral liver. The HCC patients
with a high value of DCP before TACE would clinically have a high risk of the energy malnutrition after TACE.
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Transcatheter arterial chemoembolization (TACE) is an
effective treatment for hepatocellular carcinoma (HCC)
that can deteriorate liver function. The long-term dete-
rioration of liver function after TACE can originate from
the progression of energy malnutrition (Saito et al.
2012a). In general, the non-protein respiratory quotient
(npRQ) is the main factor used to evaluate energy me-
tabolism on the basis of indirect calorimetry (Tajika* Correspondence: azumat@med.kobe-u.ac.jp
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in any medium, provided the original work is pet al. 2002). Short-term reduction in npRQ was found to
be related to long-term liver dysfunction after TACE
(Saito et al. 2012a). On the other hand, no background
characteristic factors that could promote the development
of energy malnutrition after TACE have been identified.
We aimed to clarify the background factors related to
npRQ reduction after TACE.
We performed a prospective cohort study on a total of
100 patients (mean age: 70.9 years, range: 41-87 years;
male:female ratio: 61:39) who underwent TACE for
HCC. All patients were Japanese and had liver cirrhosis.
Overall, 58 patients were classified into Child’s grade A
and 42 were classified into grade B. The etiology ofOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Figure 1 The correlation between non-protein respiratory
quotient (npRQ) ratio (Day 7/Day 0) and des-γ-carboxy
prothrombin (DCP) (Day 0) in hepatocellular carcinoma (HCC)
patients undergoing transcatheter arterial chemoembolization
(TACE). The npRQ ratio (Day 7/Day 0) was significantly related to
des-γ-carboxy prothrombin (DCP) (Day 0) in HCC patients
undergoing TACE by Pearson’s correlation coefficient test (p=0.0481,
r=-0.2033).
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http://www.springerplus.com/content/1/1/55cirrhosis was as follows: hepatitis B in 12 patients, hepa-
titis C in 71, alcoholic liver dysfunction in 28, primary
biliary cirrhosis in 2, autoimmune hepatitis in 2, non-
alcoholic fatty liver disease in 5, and unknown in 1,
although each category overlaps with others. Blood bio-
chemical examinations were performed before TACE
and indirect calorimetry was performed before and 7
days after TACE. The therapeutic volume was calculated
from the distribution of Lipiodol deposits on a liver CT
scan after TACE. The relationship between two variables
was investigated by Spearman’s correlation coefficient
test. Logarithmic transformation was performed only
when variables displayed skewed distributions.
Spearman’s correlation coefficient test showed that
npRQ ratio (Day 7/Day 0) was significantly related to
des-γ-carboxy prothrombin (DCP) (Day 0) (Figure 1:
p=0.0481, r=-0.2033). The npRQ ratio was not related to
any other blood biochemical factors (Day 0) (platelets,
lymphocytes, aspartate aminotransferase, alanine amino-
transferase, γ-glutamyltranspeptidase, total bilirubin,
cholinesterase, albumin, prealbumin, branched-chain
amino acid/tyrosine ratio, C-reactive protein, glucose, in-
sulin, HOMA-IR, hemoglobin A1c, indocyanine green
test retention rate at 15 min, type 4 collagen 7S, hyalu-
ronic acid, and alpha fetoprotein) or the therapeutic vo-
lume (p>0.05). In addition, the npRQ ratio was not also
related to alpha fetoprotein (Day 0) (p=0.6254, r=-0.0494).
In general, DCP is an HCC tumor marker (Liebman
et al. 1984). In this study, DCP was significantly related
to the TNM stage and BCLC stage of HCC (p=0.0072
and 0.0001, respectively). On the other hand, DCP pro-
duction is stimulated by hypoxia in human samples(Murata et al. 2010). Liver cirrhosis is associated with a
state of hypoxia (Le Couteur et al. 1999). In liver cirrho-
sis, the increased resistance to blood flow and oxygen
delivery due to an organized basement membrane
results in hypoxia (Le Couteur et al. 1999). A recent
study showed that serum DCP level was raised in cir-
rhotic patients without HCC, especially among liver
transplant candidates (Yamashiki et al. 2011). Our pre-
vious study also showed that HCC patients against a
background of liver cirrhosis with a high level of DCP
before TACE would become sensitive to hypoxia, and
that the tolerability for hypoxia of non-tumoral liver
after TACE would decrease (Saito et al. 2012b). In
addition, a previous study showed that the severe hy-
poxic state in the liver parenchyma would influence the
decrease of npRQ (Mimura & Furuya 1995). In this
study, npRQ reduction after TACE was not affected by
the treated size of HCC (p>0.05). It was suggested that
cancer cells did not play any positively supportive roles
of energy metabolism. Therefore, it was suggested that
the HCC patients against a background of cirrhosis with
a severe hypoxic state would easily develop npRQ reduc-
tion after TACE.
In conclusion, npRQ reduction after TACE was related
to a high value of DCP before TACE. The energy malnu-
trition after TACE would originate from low tolerability
for hypoxia of non-tumoral liver. The HCC patients with
a high value of DCP before TACE would clinically have
a high risk of the energy malnutrition after TACE.
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